Skip to content
DataLookout
Menu

NCT07916688

Lactic Acid Bacteria in Functional Diarrheal Disorders

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Irritable Bowel Syndrome Quality of Life (IBS-QOL) Total Score at 3 Months
Timeframe: Three months after enrollment

Secondary (5)

Irritable Bowel Syndrome Quality of Life (IBS-QOL) Total Score at 6 Months
Mean Daily Stool Frequency at 3 Months
Mean Daily Stool Frequency at 6 Months
Mean Bristol Stool Form Scale Score at 3 Months
Mean Bristol Stool Form Scale Score at 6 Months

Arms and interventions

Experimental First ArmExperimental

Participants randomized to this arm will receive LL1500, a probiotic supplement containing Lactobacillus rhamnosus and Lactobacillus plantarum, once daily for 3 months, followed by crossover to matching placebo for an additional 3 months under double-blind conditions.

Placebo First ArmPlacebo comparator

Participants randomized to this arm will receive matching placebo once daily for 3 months, followed by crossover to LL1500, a probiotic supplement containing Lactobacillus rhamnosus and Lactobacillus plantarum, for an additional 3 months under double-blind conditions.

Dietary supplements: LL1500

Other: Placebo Capsule

Sites

1 site in 1 country

  • University of SzegedSzeged, Hungary